| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5693021 | European Urology | 2017 | 7 Pages |
Abstract
In this randomized trial, a pathway for the diagnosis of prostate cancer based on multiparametric magnetic resonance imaging (mpMRI) was compared with the standard pathway based on random biopsy. The mpMRI-based pathway had better performance than the standard pathway.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Francesco Porpiglia, Matteo Manfredi, Fabrizio Mele, Marco Cossu, Enrico Bollito, Andrea Veltri, Stefano Cirillo, Daniele Regge, Riccardo Faletti, Roberto Passera, Cristian Fiori, Stefano De Luca,